Edge SB - Search Results

1

Alcohol consumption in relation to aberrant DNA methylation in breast tumors.

Tao MH, Marian C, Shields PG, Nie J, McCann SE, Millen A, Ambrosone C, Hutson A, Edge SB, Krishnan SS, Xie B, Winston J, Vito D, Russell M, Nochajski TH, Trevisan M, Freudenheim JL. Tao MH, et al. Among authors: edge sb. Alcohol. 2011 Nov;45(7):689-99. doi: 10.1016/j.alcohol.2010.11.006. Epub 2010 Dec 18. Alcohol. 2011. PMID: 21168302 Free PMC article.

2

Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.

Asch HL, Winston JS, Edge SB, Stomper PC, Asch BB. Asch HL, et al. Among authors: edge sb. Breast Cancer Res Treat. 1999 May;55(2):179-88. doi: 10.1023/a:1006203632228. Breast Cancer Res Treat. 1999. PMID: 10481945

3

Downregulation of gelsolin correlates with the progression to breast carcinoma.

Winston JS, Asch HL, Zhang PJ, Edge SB, Hyland A, Asch BB. Winston JS, et al. Among authors: edge sb. Breast Cancer Res Treat. 2001 Jan;65(1):11-21. doi: 10.1023/a:1006446108411. Breast Cancer Res Treat. 2001. PMID: 11245335

4

Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection.

Kane JM 3rd, Edge SB, Winston JS, Watroba N, Hurd TC. Kane JM 3rd, et al. Among authors: edge sb. Ann Surg Oncol. 2001 May;8(4):361-7. doi: 10.1007/s10434-001-0361-5. Ann Surg Oncol. 2001. PMID: 11352311

5

Accuracy of sentinel node biopsy in predicting nodal status in patients with breast carcinoma.

Sabel MS, Zhang P, Barnwell JM, Winston JS, Hurd TC, Edge SB. Sabel MS, et al. Among authors: edge sb. J Surg Oncol. 2001 Aug;77(4):243-6. doi: 10.1002/jso.1103. J Surg Oncol. 2001. PMID: 11473372

6

Altered expression and localization of PKC eta in human breast tumors.

Masso-Welch PA, Winston JS, Edge S, Darcy KM, Asch H, Vaughan MM, Ip MM. Masso-Welch PA, et al. Breast Cancer Res Treat. 2001 Aug;68(3):211-23. doi: 10.1023/a:1012265703669. Breast Cancer Res Treat. 2001. PMID: 11727958

7

Breast cancer risk factors and HER2 over-expression in tumors.

Swede H, Moysich KB, Freudenheim JL, Quirk JT, Muti PC, Hurd TC, Edge SB, Winston JS, Michalek AM. Swede H, et al. Among authors: edge sb. Cancer Detect Prev. 2001;25(6):511-9. Cancer Detect Prev. 2001. PMID: 12132871

8

Concordance with breast cancer pathology reporting practice guidelines.

Wilkinson NW, Shahryarinejad A, Winston JS, Watroba N, Edge SB. Wilkinson NW, et al. Among authors: edge sb. J Am Coll Surg. 2003 Jan;196(1):38-43. doi: 10.1016/s1072-7515(02)01627-7. J Am Coll Surg. 2003. PMID: 12517547

9

Variation of the prognostic significance of HER-2 expression in breast cancer according to tumor size.

Swede H, Moysich KB, Winston JS, Hurd TC, Edge SB, Romero-Gutierrez M, Brooks JS, Michalek AM. Swede H, et al. Among authors: edge sb. Breast J. 2003 Mar-Apr;9(2):98-105. doi: 10.1046/j.1524-4741.2003.09207.x. Breast J. 2003. PMID: 12603382

10

Dietary lignan intakes and risk of pre- and postmenopausal breast cancer.

McCann SE, Muti P, Vito D, Edge SB, Trevisan M, Freudenheim JL. McCann SE, et al. Among authors: edge sb. Int J Cancer. 2004 Sep 1;111(3):440-3. doi: 10.1002/ijc.20262. Int J Cancer. 2004. PMID: 15221974 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

257 results

Search Page